Valsartan and Hydrochlorothiazide
- Product NDC
- 50090-6210
- 11-digit product format
- 500906210
- Labeler code
- 50090
- Product ID
- 50090-6210_e98a3ea5-8cfb-4866-ad6e-fab47a05c705
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Valsartan and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA203145
- Marketing category
- ANDA
- Marketing start
- 2013-04-19
- Substance
- HYDROCHLOROTHIAZIDE; VALSARTAN
- Active strength
- 25; 160 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
| 80M03YXJ7I | VALSARTAN | 137862-53-4 | VALSARTAN |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6210-0 | 50090621000 | 90 TABLET in 1 BOTTLE (50090-6210-0) | 90 tablet | 2022-11-07 | No | No | Historical |